SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-012915
Filing Date
2020-11-05
Accepted
2020-11-05 16:44:40
Documents
77
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q clvs-20200930x10q.htm   iXBRL 10-Q 2507964
2 EX-31.1 clvs-20200930xex31d1.htm EX-31.1 15854
3 EX-31.2 clvs-20200930xex31d2.htm EX-31.2 16047
4 EX-32.1 clvs-20200930xex32d1.htm EX-32.1 6468
5 EX-32.2 clvs-20200930xex32d2.htm EX-32.2 6548
  Complete submission text file 0001558370-20-012915.txt   9443973

Data Files

Seq Description Document Type Size
6 EX-101.SCH clvs-20200930.xsd EX-101.SCH 58526
7 EX-101.CAL clvs-20200930_cal.xml EX-101.CAL 82986
8 EX-101.DEF clvs-20200930_def.xml EX-101.DEF 173149
9 EX-101.LAB clvs-20200930_lab.xml EX-101.LAB 604054
10 EX-101.PRE clvs-20200930_pre.xml EX-101.PRE 391377
11 EXTRACTED XBRL INSTANCE DOCUMENT clvs-20200930x10q_htm.xml XML 1774827
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35347 | Film No.: 201291204
SIC: 2834 Pharmaceutical Preparations